A new trading day began on Monday, with NeuroPace Inc (NASDAQ: NPCE) stock price down -8.80% from the previous day of trading, before settling in for the closing price of $12.95. NPCE’s price has ranged from $5.45 to $17.10 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 16.39%. Meanwhile, its annual earnings per share averaged 22.67%. With a float of $21.64 million, this company’s outstanding shares have now reached $29.78 million.
The extent of productivity of a business whose workforce counts for 171 workers is very important to gauge. In terms of profitability, gross margin is 73.83%, operating margin of -30.17%, and the pretax margin is -36.74%.
NeuroPace Inc (NPCE) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of NeuroPace Inc is 30.35%, while institutional ownership is 39.22%. The most recent insider transaction that took place on Feb 21 ’25, was worth 1,074,844. In this transaction CHIEF MEDICAL OFFICER of this company sold 78,334 shares at a rate of $13.72, taking the stock ownership to the 81,993 shares. Before that another transaction happened on Feb 20 ’25, when Company’s 10% Owner sold 5,270,845 for $9.40, making the entire transaction worth $49,545,943. This insider now owns 0 shares in total.
NeuroPace Inc (NPCE) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.65% during the next five years compared to -0.33% drop over the previous five years of trading.
NeuroPace Inc (NASDAQ: NPCE) Trading Performance Indicators
Here are NeuroPace Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.99, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.89 in one year’s time.
Technical Analysis of NeuroPace Inc (NPCE)
The latest stats from [NeuroPace Inc, NPCE] show that its last 5-days average volume of 0.26 million was superior to 0.24 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 30.03%. Additionally, its Average True Range was 1.04.
During the past 100 days, NeuroPace Inc’s (NPCE) raw stochastic average was set at 65.84%, which indicates a significant increase from 36.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.78% in the past 14 days, which was lower than the 76.21% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.65, while its 200-day Moving Average is $8.86. Now, the first resistance to watch is $12.55. This is followed by the second major resistance level at $13.29. The third major resistance level sits at $13.71. If the price goes on to break the first support level at $11.39, it is likely to go to the next support level at $10.97. The third support level lies at $10.23 if the price breaches the second support level.
NeuroPace Inc (NASDAQ: NPCE) Key Stats
With a market capitalization of 367.02 million, the company has a total of 29,848K Shares Outstanding. Currently, annual sales are 65,420 K while annual income is -32,960 K. The company’s previous quarter sales were 21,060 K while its latest quarter income was -5,450 K.
